(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKACA mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:1552640 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRKACA mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases activity ISO RGD:1344608 6480464 o, p'-DDT results in increased activity of PRKACA protein CTD PMID:19526567 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases activity EXP 6480464 o, p'-DDT results in decreased activity of PRKACA protein CTD PMID:23209616 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of PRKACA mRNA CTD PMID:27840820 14-Deoxy-11,12-didehydroandrographolide multiple interactions ISO RGD:1552640 6480464 14-deoxy-11, 12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of PRKACA protein] CTD PMID:30248417 17alpha-ethynylestradiol increases expression ISO RGD:1552640 6480464 Ethinyl Estradiol results in increased expression of PRKACA mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1344608 6480464 PRKACA protein affects the reaction [Ethinyl Estradiol results in decreased expression of ABCB11 mRNA] more ... CTD PMID:27743861 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552640 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKACA mRNA CTD PMID:15667827 , PMID:17407152 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKACA mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552640 6480464 Tetrachlorodibenzodioxin affects the expression of PRKACA mRNA CTD PMID:21570461 2-tert-butylhydroquinone increases expression ISO RGD:1552640 6480464 2-tert-butylhydroquinone results in increased expression of PRKACA mRNA CTD PMID:16014739 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1552640 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PRKACA mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1552640 6480464 14-deoxy-11 more ... CTD PMID:29288687 , PMID:30248417 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1552640 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PRKACA mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PRKACA mRNA CTD PMID:36041667 4-aminopyridine increases phosphorylation EXP 6480464 4-Aminopyridine results in increased phosphorylation of PRKACA protein CTD PMID:35643327 4-aminopyridine multiple interactions EXP 6480464 lappaconitine inhibits the reaction [4-Aminopyridine results in increased phosphorylation of PRKACA protein] CTD PMID:35643327 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PRKACA mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:1344608 6480464 Antimycin A results in decreased expression of PRKACA mRNA CTD PMID:33512557 aristolochic acid A increases expression ISO RGD:1344608 6480464 aristolochic acid I results in increased expression of PRKACA mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:1552640 6480464 arsenite results in increased expression of PRKACA mRNA CTD PMID:18191166 asbestos affects expression ISO RGD:1344608 6480464 Asbestos affects the expression of PRKACA mRNA CTD PMID:17297452 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein, N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein] CTD PMID:19053045 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of PRKACA mRNA, Atrazine results in decreased expression of PRKACA protein CTD PMID:30065202 BAPTA multiple interactions EXP 6480464 1 more ... CTD PMID:21863293 belinostat increases expression ISO RGD:1344608 6480464 belinostat results in increased expression of PRKACA mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:1344608 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA CTD PMID:27188386 benzo[a]pyrene affects methylation ISO RGD:1344608 6480464 Benzo(a)pyrene affects the methylation of PRKACA intron, Benzo(a)pyrene affects the methylation of PRKACA promoter CTD PMID:27901495 , PMID:30157460 bis(2-ethylhexyl) phthalate decreases phosphorylation ISO RGD:1552640 6480464 Diethylhexyl Phthalate results in decreased phosphorylation of PRKACA protein CTD PMID:32303808 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1552640 6480464 Diethylhexyl Phthalate promotes the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Dietary Sugars] results in decreased phosphorylation of PRKACA protein] CTD PMID:32303808 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PRKACA mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of PRKACA mRNA CTD PMID:26496021 , PMID:36041667 bisphenol A affects expression ISO RGD:1552640 6480464 bisphenol A affects the expression of PRKACA mRNA CTD PMID:35341816 bisphenol A increases expression ISO RGD:1344608 6480464 bisphenol A results in increased expression of PRKACA protein CTD PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKACA mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PRKACA mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1552640 6480464 bisphenol A results in decreased expression of PRKACA mRNA CTD PMID:26063408 Bisphenol B increases expression ISO RGD:1344608 6480464 bisphenol B results in increased expression of PRKACA protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1344608 6480464 bisphenol F results in increased expression of PRKACA protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PRKACA mRNA CTD PMID:36041667 bucladesine multiple interactions EXP 6480464 KT 5720 inhibits the reaction [Bucladesine results in increased activity of PRKACA protein] CTD PMID:31300867 bucladesine increases activity EXP 6480464 Bucladesine results in increased activity of PRKACA protein CTD PMID:31300867 buprenorphine decreases activity EXP 6480464 Buprenorphine results in decreased activity of PRKACA protein CTD PMID:24321744 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of PRKACA mRNA CTD PMID:24136188 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of PRKACA protein CTD PMID:25981801 cadmium atom multiple interactions ISO RGD:1344608 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRKACA mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PRKACA protein CTD PMID:25981801 , PMID:29214744 cadmium dichloride multiple interactions ISO RGD:1344608 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRKACA mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO RGD:1552640 6480464 Cadmium Chloride results in decreased expression of PRKACA protein CTD PMID:31014900 cadmium dichloride multiple interactions ISO RGD:1552640 6480464 cyanidin-3-O-beta-glucopyranoside inhibits the reaction [Cadmium Chloride results in decreased expression of PRKACA protein] CTD PMID:31014900 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of PRKACA protein CTD PMID:30825513 caffeine decreases phosphorylation ISO RGD:1344608 6480464 Caffeine results in decreased phosphorylation of PRKACA protein CTD PMID:35688186 caffeine decreases expression ISO RGD:1344608 6480464 Caffeine results in decreased expression of PRKACA protein CTD PMID:30825513 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of PRKACA gene CTD PMID:30521419 cannabidiol multiple interactions ISO RGD:1344608 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of PRKACA mRNA CTD PMID:30096889 capsaicin increases phosphorylation ISO RGD:1552640 6480464 Capsaicin results in increased phosphorylation of PRKACA protein CTD PMID:21908651 captopril multiple interactions EXP 6480464 Captopril inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] CTD PMID:31629013 CGP 52608 multiple interactions ISO RGD:1344608 6480464 CGP 52608 promotes the reaction [RORA protein binds to PRKACA gene] CTD PMID:28238834 chaetocin multiple interactions EXP 6480464 chaetocin inhibits the reaction [Dronabinol results in decreased expression of PRKACA mRNA] CTD PMID:29022873 , PMID:29481316 chlorpyrifos decreases expression ISO RGD:1552640 6480464 Chlorpyrifos results in decreased expression of PRKACA mRNA CTD PMID:32715474 cisplatin multiple interactions ISO RGD:1344608 6480464 [PRKACA results in increased phosphorylation of BAD protein] which results in decreased susceptibility to Cisplatin CTD PMID:21849418 cisplatin increases expression ISO RGD:1344608 6480464 Cisplatin results in increased expression of PRKACA mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1344608 6480464 Cisplatin results in decreased expression of PRKACA mRNA CTD PMID:27594783 clenbuterol multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] CTD PMID:16339297 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PRKACA mRNA CTD PMID:15860345 cobalt dichloride decreases expression ISO RGD:1344608 6480464 cobaltous chloride results in decreased expression of PRKACA mRNA CTD PMID:19320972 cocaine multiple interactions EXP 6480464 [Cocaine affects the activity of PRKACA protein] which affects the phosphorylation of DPYSL2 protein more ... CTD PMID:12595601 , PMID:19457111 cocaine affects expression EXP 6480464 Cocaine affects the expression of PRKACA protein CTD PMID:15659224 cocaine affects activity EXP 6480464 Cocaine affects the activity of PRKACA protein CTD PMID:19457111 colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] CTD PMID:16339297 colforsin daropate hydrochloride increases activity ISO RGD:1344608 6480464 Colforsin results in increased activity of PRKACA protein CTD PMID:28601556 daidzein multiple interactions ISO RGD:1344608 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO RGD:1344608 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 deguelin decreases expression ISO RGD:1344608 6480464 deguelin results in decreased expression of PRKACA mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:1552640 6480464 14-deoxy-11 more ... CTD PMID:29288687 , PMID:30248417 dicrotophos increases expression ISO RGD:1344608 6480464 dicrotophos results in increased expression of PRKACA mRNA CTD PMID:28302478 dobutamine multiple interactions EXP 6480464 Dobutamine inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] CTD PMID:16339297 dorsomorphin multiple interactions ISO RGD:1344608 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1344608 6480464 Doxorubicin results in increased expression of PRKACA mRNA CTD PMID:16404146 epoxiconazole decreases expression ISO RGD:1552640 6480464 epoxiconazole results in decreased expression of PRKACA mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PRKACA mRNA CTD PMID:20655511 ethanol multiple interactions ISO RGD:1552640 6480464 Ethanol affects the expression of and affects the splicing of PRKACA mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1344608 6480464 Ethyl Methanesulfonate results in increased expression of PRKACA mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO RGD:1552640 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PRKACA mRNA CTD PMID:28329830 formaldehyde increases expression ISO RGD:1344608 6480464 Formaldehyde results in increased expression of PRKACA mRNA CTD PMID:23649840 genistein multiple interactions ISO RGD:1344608 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 genistein 7-O-beta-D-glucoside multiple interactions ISO RGD:1344608 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PRKACA mRNA CTD PMID:33387578 glycitein multiple interactions ISO RGD:1344608 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 glycitin multiple interactions ISO RGD:1344608 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 glyphosate decreases expression ISO RGD:1344608 6480464 glyphosate results in decreased expression of PRKACA mRNA CTD PMID:31295307 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of PRKACA mRNA CTD PMID:15860345 hydrogen peroxide multiple interactions ISO RGD:1344608 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of PRKACA protein CTD PMID:18951874 hydrogen sulfide increases phosphorylation ISO RGD:1552640 6480464 Hydrogen Sulfide results in increased phosphorylation of PRKACA protein CTD PMID:31843631 hydroxysafflor yellow A multiple interactions EXP 6480464 hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased activity of PRKACA protein]] more ... CTD PMID:24192212 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of PRKACA mRNA CTD PMID:30303030 ivermectin decreases expression ISO RGD:1344608 6480464 Ivermectin results in decreased expression of PRKACA protein CTD PMID:32959892 KT 5720 multiple interactions EXP 6480464 KT 5720 inhibits the reaction [Bucladesine results in increased activity of PRKACA protein], KT 5720 inhibits the reaction [Taurolithocholic Acid results in increased activity of PRKACA protein] CTD PMID:31300867 Lappaconitine multiple interactions EXP 6480464 lappaconitine inhibits the reaction [4-Aminopyridine results in increased phosphorylation of PRKACA protein] CTD PMID:35643327 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of PRKACA protein CTD PMID:25981801 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of PRKACA protein CTD PMID:25981801 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of PRKACA protein CTD PMID:25981801 Licarin A multiple interactions ISO RGD:1552640 6480464 PRKACA protein promotes the reaction [[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of LIPE protein modified form] more ... CTD PMID:29288687 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in decreased expression of PRKACA mRNA more ... CTD PMID:27460631 , PMID:33368748 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of PRKACA protein CTD PMID:25981801 manganese atom multiple interactions EXP 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased activity of PRKACA protein CTD PMID:30951808 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of PRKACA protein CTD PMID:25981801 manganese(0) multiple interactions EXP 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased activity of PRKACA protein CTD PMID:30951808 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of PRKACA protein CTD PMID:25981801 manganese(II) chloride multiple interactions EXP 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased activity of PRKACA protein CTD PMID:30951808 mercury dibromide increases expression ISO RGD:1344608 6480464 mercuric bromide results in increased expression of PRKACA mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1344608 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA CTD PMID:27188386 methidathion decreases expression ISO RGD:1552640 6480464 methidathion results in decreased expression of PRKACA mRNA CTD PMID:34813904 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of PRKACA protein CTD PMID:29258870 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1552640 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PRKACA mRNA CTD PMID:25543134 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRKACA mRNA CTD PMID:28659758 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein] CTD PMID:19053045 N-methyl-4-phenylpyridinium affects expression ISO RGD:1344608 6480464 1-Methyl-4-phenylpyridinium affects the expression of PRKACA mRNA CTD PMID:12710931 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKACA mRNA CTD PMID:20360939 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PRKACA protein CTD PMID:29698782 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PRKACA mRNA CTD PMID:24136188 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1344608 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of PRKACA gene CTD PMID:30521419 ochratoxin A increases acetylation ISO RGD:1344608 6480464 ochratoxin A results in increased acetylation of PRKACA promoter CTD PMID:29098329 ochratoxin A multiple interactions ISO RGD:1344608 6480464 [ochratoxin A results in increased acetylation of PRKACA promoter] which results in increased expression of PRKACA mRNA CTD PMID:29098329 ochratoxin A increases expression ISO RGD:1344608 6480464 ochratoxin A results in increased expression of PRKACA mRNA CTD PMID:29098329 oxidopamine decreases phosphorylation EXP 6480464 Oxidopamine results in decreased phosphorylation of PRKACA protein CTD PMID:16339297 oxidopamine multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] more ... CTD PMID:16339297 oxycodone increases phosphorylation EXP 6480464 Oxycodone results in increased phosphorylation of PRKACA protein CTD PMID:26377394 panobinostat multiple interactions ISO RGD:1344608 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1344608 6480464 panobinostat results in increased expression of PRKACA mRNA CTD PMID:26272509 paracetamol increases expression ISO RGD:1344608 6480464 Acetaminophen results in increased expression of PRKACA mRNA CTD PMID:25704631 paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in decreased expression of PRKACA mRNA more ... CTD PMID:27460631 , PMID:33368748 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1552640 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRKACA mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PRKACA mRNA CTD PMID:19162173 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRKACA mRNA CTD PMID:28659758 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKACA mRNA CTD PMID:20360939 phenobarbital affects expression ISO RGD:1552640 6480464 Phenobarbital affects the expression of PRKACA mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1344608 6480464 Phenylmercuric Acetate results in increased expression of PRKACA mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1344608 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PRKACA mRNA CTD PMID:19162173 pregabalin multiple interactions EXP 6480464 Captopril inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein], Telmisartan inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] CTD PMID:31629013 pregabalin decreases expression EXP 6480464 Pregabalin results in decreased expression of PRKACA protein CTD PMID:31629013 prostaglandin E2 multiple interactions ISO RGD:1344608 6480464 [Dinoprostone co-treated with PTGER1 protein] results in increased phosphorylation of PRKACA protein CTD PMID:22188298 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRKACA mRNA CTD PMID:28659758 pyrimidifen decreases expression ISO RGD:1344608 6480464 pyrimidifen results in decreased expression of PRKACA mRNA CTD PMID:33512557 quercetin multiple interactions EXP 6480464 PRKACA protein affects the reaction [Quercetin results in increased expression of EGR1 mRNA], PRKACA protein affects the reaction [Quercetin results in increased expression of EGR1 protein] CTD PMID:22174042 reserpine decreases expression ISO RGD:1552640 6480464 Reserpine results in decreased expression of PRKACA protein CTD PMID:26114099 resveratrol multiple interactions ISO RGD:1344608 6480464 [TNF protein co-treated with Resveratrol] results in increased expression of PRKACA protein more ... CTD PMID:24145604 , PMID:25943029 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PRKACA mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:1344608 6480464 Rotenone results in decreased expression of PRKACA mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1344608 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases methylation ISO RGD:1344608 6480464 Asbestos, Serpentine results in decreased methylation of PRKACA 3' UTR CTD PMID:29523930 sodium arsenite decreases expression ISO RGD:1344608 6480464 sodium arsenite results in decreased expression of PRKACA mRNA CTD PMID:12760830 sodium arsenite increases expression ISO RGD:1344608 6480464 sodium arsenite results in increased expression of PRKACA mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:1552640 6480464 sodium arsenite results in increased expression of PRKACA mRNA CTD PMID:16014739 sodium fluoride increases expression ISO RGD:1552640 6480464 Sodium Fluoride results in increased expression of PRKACA protein CTD PMID:28918527 streptozocin multiple interactions ISO RGD:1552640 6480464 [Streptozocin co-treated with Dietary Fats co-treated with Dietary Sugars] results in decreased phosphorylation of PRKACA protein, Diethylhexyl Phthalate promotes the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Dietary Sugars] results in decreased phosphorylation of PRKACA protein] CTD PMID:32303808 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKACA mRNA CTD PMID:20371263 sulindac sulfide increases expression ISO RGD:1344608 6480464 sulindac sulfide results in increased expression of PRKACA mRNA CTD PMID:16184548 sunitinib decreases expression ISO RGD:1344608 6480464 Sunitinib results in decreased expression of PRKACA mRNA CTD PMID:31533062 tamibarotene increases expression ISO RGD:1344608 6480464 tamibarotene results in increased expression of PRKACA mRNA CTD PMID:17229644 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [[Paraquat co-treated with Maneb] results in decreased expression of PRKACA mRNA] CTD PMID:33368748 taurolithocholic acid increases activity EXP 6480464 Taurolithocholic Acid results in increased activity of PRKACA protein CTD PMID:31300867 taurolithocholic acid multiple interactions EXP 6480464 JTE 013 inhibits the reaction [Taurolithocholic Acid results in increased activity of PRKACA protein] more ... CTD PMID:31300867 tebufenpyrad decreases expression ISO RGD:1344608 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of PRKACA mRNA CTD PMID:33512557 telmisartan multiple interactions EXP 6480464 Telmisartan inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] CTD PMID:31629013 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of PRKACA mRNA CTD PMID:26496021 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PRKACA mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1552640 6480464 Carbon Tetrachloride results in decreased expression of PRKACA mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKACA mRNA] CTD PMID:31150632 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of PRKACA protein CTD PMID:35544339 theophylline multiple interactions ISO RGD:1344608 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of PRKACA protein CTD PMID:18951874 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PRKACA mRNA CTD PMID:23411599 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PRKACA mRNA CTD PMID:19448997 , PMID:33387578 triclosan increases expression EXP 6480464 Triclosan results in increased expression of PRKACA mRNA CTD PMID:30447264 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PRKACA mRNA CTD PMID:23639586 Tylophorine increases expression ISO RGD:1344608 6480464 tylophorine analog results in increased expression of PRKACA mRNA CTD PMID:19284764 urethane increases expression ISO RGD:1344608 6480464 Urethane results in increased expression of PRKACA mRNA CTD PMID:28818685 valproic acid increases methylation ISO RGD:1344608 6480464 Valproic Acid results in increased methylation of PRKACA gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PRKACA mRNA CTD PMID:32428529 valproic acid increases expression ISO RGD:1344608 6480464 Valproic Acid results in increased expression of PRKACA mRNA CTD PMID:23179753 vanadium atom decreases expression ISO RGD:1344608 6480464 Vanadium results in decreased expression of PRKACA mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO RGD:1344608 6480464 Vanadium results in decreased expression of PRKACA mRNA CTD PMID:19000753 vismodegib increases expression ISO RGD:1344608 150573695 vismodegib increases protein kinase A protein expression in pituitary adenoma cells RGD
